Clinical Trial Update: Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating high-intensity focused ultrasound for unresectable pancreatic cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Centre Leon Berard | Conditions: Non-Resectable Pancreas Carcinoma | Phase 1, Phase 2 | Status: SUSPENDED